Michael J. Lukey
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 12
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism 6
-
- Electrocatalysts for Energy Conversion 4
- Metalloenzymes and iron-sulfur proteins 4
- Biotechnology top 5%
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine 2
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Richard A. CerioneAhmad A. CluntunJason W. LocasaleWilliam P. KattKristin F. WilsonAlison ParkinFräser A. ArmstrongFrank Sargent
- Journals
- Journal of the American Chemical Society (3 papers)Journal of Biological Chemistry (3 papers)Future Medicinal Chemistry (2 papers)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Michael J. Lukey
21 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 1.0k
- Biochemistry 203
- Renewable Energy, Sustainability and the Environment 379
- Biotechnology 171
- Geriatrics and Gerontology 77
Countries citing papers authored by Michael J. Lukey
This map shows the geographic impact of Michael J. Lukey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Lukey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Lukey more than expected).
Fields of papers citing papers by Michael J. Lukey
This network shows the impact of papers produced by Michael J. Lukey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Lukey. The network helps show where Michael J. Lukey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael J. Lukey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 66 | |
| 6 | 2022 | 15 | |
| 7 | Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapybreakdown → | 2021 | 192 |
| 8 | 2020 | 12 | |
| 9 | 2019 | 94 | |
| 10 | 2019 | 75 | |
| 11 | Glutamine Metabolism in Cancer: Understanding the Heterogeneitybreakdown → | 2017 | 571 |
| 12 | 2016 | 144 | |
| 13 | 2016 | 229 | |
| 14 | 2013 | 77 | |
| 15 | 2013 | 115 | |
| 16 | 2012 | 138 | |
| 17 | 2011 | 105 | |
| 18 | 2010 | 11 | |
| 19 | 2009 | 46 | |
| 20 | 2009 | 193 |
About Michael J. Lukey
Michael J. Lukey is a scholar working on Biochemistry, Cancer Research, Geriatrics and Gerontology, Toxicology and Renewable Energy, Sustainability and the Environment, having authored 21 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Amino Acid Enzymes and Metabolism (6 papers), Epigenetics and DNA Methylation (5 papers), Electrocatalysts for Energy Conversion (4 papers), Metalloenzymes and iron-sulfur proteins (4 papers), RNA modifications and cancer (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Cancer Research (1.0k citations), Biochemistry (203 citations), Renewable Energy, Sustainability and the Environment (379 citations), Biotechnology (171 citations) and Geriatrics and Gerontology (77 citations). Michael J. Lukey has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Richard A. Cerione, Ahmad A. Cluntun, Jason W. Locasale, William P. Katt, Kristin F. Wilson, Alison Parkin, Fräser A. Armstrong, Frank Sargent, Kai Su Greene and Maxie M. Roessler. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry, Future Medicinal Chemistry, Trends in cancer and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.